Estimating prion concentration in fluids and tissues by quantitative PMCA (original) (raw)

Nature Methods volume 7, pages 519–520 (2010)Cite this article

Subjects

Abstract

Prions, the proteinaceous infectious agent responsible for prion diseases, can be detected with high sensitivity by protein misfolding cyclic amplification (PMCA) technology. Here we describe a quantitative PMCA procedure to calculate the concentration of very low levels of prions in biological samples. Using this procedure, we determined the quantities of misfolded prion protein (PrPSc) in brain, spleen, blood and urine of scrapie-affected hamsters.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$259.00 per year

only $21.58 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. Aguzzi, A. & Calella, A.M. Physiol. Rev. 89, 1105–1152 (2009).
    Article CAS Google Scholar
  2. Soto, C. Nat. Rev. Microbiol. 2, 809–819 (2004).
    Article CAS Google Scholar
  3. Brown, P. Neurology 70, 713–722 (2008).
    Article Google Scholar
  4. Wadsworth, J.D. et al. Lancet 358, 171–180 (2001).
    Article CAS Google Scholar
  5. Saborio, G.P., Permanne, B. & Soto, C. Nature 411, 810–813 (2001).
    Article CAS Google Scholar
  6. Saa, P., Castilla, J. & Soto, C. J. Biol. Chem. 281, 35245–35252 (2006).
    Article CAS Google Scholar
  7. Castilla, J., Saa, P. & Soto, C. Nat. Med. 11, 982–985 (2005).
    Article CAS Google Scholar
  8. Saa, P., Castilla, J. & Soto, C. Science 313, 92–94 (2006).
    Article CAS Google Scholar
  9. Thorne, L. & Terry, L.A. J. Gen. Virol. 89, 3177–3184 (2008).
    Article CAS Google Scholar
  10. Murayama, Y. et al. J. Gen. Virol. 88, 2890–2898 (2007).
    Article CAS Google Scholar
  11. Gonzalez-Romero, D., Barria, M.A., Leon, P., Morales, R. & Soto, C. FEBS Lett. 582, 3161–3166 (2008).
    Article CAS Google Scholar
  12. Morales, R. et al. Biochem. Biophys. Res. Commun. 377, 373–378 (2008).
    Article CAS Google Scholar
  13. Castilla, J. et al. Methods Enzymol. 412, 3–21 (2006).
    Article CAS Google Scholar
  14. Castilla, J., Saá, P., Hetz, C. & Soto, C. Cell 121, 195–206 (2005).
    Article CAS Google Scholar
  15. Saa, P., Castilla, J. & Soto, C. Methods Mol. Biol. 299, 53–65 (2005).
    CAS PubMed Google Scholar

Download references

Acknowledgements

We thank D. Gonzalez-Romero (University of Texas Houston Medical School) for participating in the PMCA experiments with urine, R. Diaz-Espinoza (University of Texas Houston Medical School) for providing recombinant PrP and D. Zhao (China Agricultural University) for suggestions and providing support to B.C. This research was supported in part by US National Institutes of Health grants R01NS049173 and P01AI077774 to C.S.

Author information

Authors and Affiliations

  1. Department of Neurology, Mitchell Center for Alzheimer's Disease and Related Brain Disorders, University of Texas Houston Medical School, Houston, Texas, USA
    Baian Chen, Rodrigo Morales, Marcelo A Barria & Claudio Soto
  2. National Animal Transmissible Spongiform Encephalopathies (TSE) Lab, College of Veterinary Medicine, China Agricultural University,, Beijing, China
    Baian Chen

Authors

  1. Baian Chen
    You can also search for this author inPubMed Google Scholar
  2. Rodrigo Morales
    You can also search for this author inPubMed Google Scholar
  3. Marcelo A Barria
    You can also search for this author inPubMed Google Scholar
  4. Claudio Soto
    You can also search for this author inPubMed Google Scholar

Contributions

B.C. performed most of the experiments, analyzed the data and prepared the figures; R.M. helped with experimental design and data analysis; M.A.B. performed the PMCA experiments in blood; and C.S. developed the hypothesis, designed and analyzed all data, wrote the manuscript and supervised the project.

Corresponding author

Correspondence toClaudio Soto.

Ethics declarations

Competing interests

C.S. is inventor of the PMCA technology and is founder, vice-president and chief scientific officer of Amprion, Inc, a biotechnology company focused on developing technologies to detect misfolded proteins associated with neurodegenerative diseases.

Rights and permissions

About this article

Cite this article

Chen, B., Morales, R., Barria, M. et al. Estimating prion concentration in fluids and tissues by quantitative PMCA.Nat Methods 7, 519–520 (2010). https://doi.org/10.1038/nmeth.1465

Download citation

This article is cited by